|
|
ATON
PAR •
Healthcare •
Biotechnology •
Quote as of 05/18/2026 17:35
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangePAR
Market Capitalization14.08 mln
Float321 mln
Relative Strength
83
/ 100
Strongly outperforming
Debt / Equity
10.02
Extremely leveraged
Key Fundamentals
RPS0.00
ROIC4.88
ROA-2.11
Interest Cover6.08
EBITDA, mln0.89
EV / EBITDA24.25
EV / EBIT-1,537
Revenue, mln0.66
EV / Revenue32.69
Financial Strength
Altman Z-Score-3.74
Piotroski F-Score
6
/ 9
Beneish M-Score-2.91
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-13.98% |
1
/ 100
 |
| 1 Month |
167% |
100
/ 100
 |
| 2 Months |
167% |
99
/ 100
 |
| 6 Months |
116% |
99
/ 100
|
| 1 Year |
90.48% |
96
/ 100
|
|
| |
